No connection

Search Results

Analysis Neutral

Nurix Therapeutics Posts Wider Loss In Q1

Apr 08, 2026 10:57 UTC

(RTTNews) - Nurix Therapeutics, Inc. (NRIX) reported a first quarter net loss of $87.2 million or $0.79 per share compared with a net loss of $56.4 million or $0.67 per share, prior year.

  • April 08, 2026 — 06:57 am EDT Written byRTTNews
  • comforRTTNews-> (RTTNews) - Nurix Therapeutics, Inc
  • (NRIX) reported a first quarter net loss of $87

April 08, 2026 — 06:57 am EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Nurix Therapeutics, Inc. (NRIX) reported a first quarter net loss of $87.2 million or $0.79 per share compared with a net loss of $56.4 million or $0.67 per share, prior year. Revenue was $6.3 million compared with $18.5 million, a year ago. The company said revenue from the collaboration with Sanofi decreased as the initial research term for certain drug targets ended. Cash, cash equivalents and marketable securitieswere $540.7 million as of February 28, 2026. In pre-market trading on NasdaqGM, Nurix shares are down 3

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile